» Articles » PMID: 37397229

The Role of Pioneer Transcription Factors in the Induction of Direct Cellular Reprogramming

Overview
Journal Regen Ther
Date 2023 Jul 3
PMID 37397229
Authors
Affiliations
Soon will be listed here.
Abstract

Regenerative medicine is a highly advanced medical field that aims to restore tissues and organs lost due to diseases and injury using a person's own cells or those of others. Direct cellular reprogramming is a promising technology that can directly induce cell-fate conversion from terminally differentiated cells to other cell types and is expected to play a pivotal role in applications in regenerative medicine. The induction of direct cellular reprogramming requires one or more master transcription factors with the potential to reconstitute cell type-specific transcription factor networks. The set of master transcription factors may contain unique transcription factors called pioneer factors that can open compacted chromatin structures and drive the transcriptional activation of target genes. Therefore, pioneer factors may play a central role in direct cellular reprogramming. However, our understanding of the molecular mechanisms by which pioneer factors induce cell-fate conversion is still limited. This review briefly summarizes the outcomes of recent findings and discusses future perspectives, focusing on the role of pioneer factors in direct cellular reprogramming.

Citing Articles

A Snapshot of Early Transcriptional Changes Accompanying the Pro-Neural Phenotype Switch by NGN2, ASCL1, SOX2, and MSI1 in Human Fibroblasts: An RNA-Seq Study.

Samoilova E, Chudakova D, Dashinimaev E, Snezhkina A, Kudryashova O, Lipatova A Int J Mol Sci. 2024; 25(22).

PMID: 39596450 PMC: 11594342. DOI: 10.3390/ijms252212385.


Single cell spatial biology over developmental time can decipher pediatric brain pathologies.

Nussinov R, Yavuz B, Jang H Neurobiol Dis. 2024; 199:106597.

PMID: 38992777 PMC: 11286356. DOI: 10.1016/j.nbd.2024.106597.


Exploring the reciprocity between pioneer factors and development.

Freund M, Harrison M, Torres-Zelada E Development. 2024; 151(13).

PMID: 38958075 PMC: 11266817. DOI: 10.1242/dev.201921.


Anticancer drugs: How to select small molecule combinations?.

Nussinov R, Yavuz B, Jang H Trends Pharmacol Sci. 2024; 45(6):503-519.

PMID: 38782689 PMC: 11162304. DOI: 10.1016/j.tips.2024.04.012.


Sox2 and βIII-Tubulin as Biomarkers of Drug Resistance in Poorly Differentiated Sinonasal Carcinomas.

Lopez L, Fernandez-Vanes L, Cabal V, Garcia-Marin R, Suarez-Fernandez L, Codina-Martinez H J Pers Med. 2023; 13(10).

PMID: 37888115 PMC: 10608336. DOI: 10.3390/jpm13101504.

References
1.
Dal-Pra S, Hodgkinson C, Mirotsou M, Kirste I, Dzau V . Demethylation of H3K27 Is Essential for the Induction of Direct Cardiac Reprogramming by miR Combo. Circ Res. 2017; 120(9):1403-1413. PMC: 5409871. DOI: 10.1161/CIRCRESAHA.116.308741. View

2.
Liu Y, Pelham-Webb B, Di Giammartino D, Li J, Kim D, Kita K . Widespread Mitotic Bookmarking by Histone Marks and Transcription Factors in Pluripotent Stem Cells. Cell Rep. 2017; 19(7):1283-1293. PMC: 5495017. DOI: 10.1016/j.celrep.2017.04.067. View

3.
Mall M, Kareta M, Chanda S, Ahlenius H, Perotti N, Zhou B . Myt1l safeguards neuronal identity by actively repressing many non-neuronal fates. Nature. 2017; 544(7649):245-249. PMC: 11348803. DOI: 10.1038/nature21722. View

4.
Ieda M, Fu J, Delgado-Olguin P, Vedantham V, Hayashi Y, Bruneau B . Direct reprogramming of fibroblasts into functional cardiomyocytes by defined factors. Cell. 2010; 142(3):375-86. PMC: 2919844. DOI: 10.1016/j.cell.2010.07.002. View

5.
Gong L, Yan Q, Zhang Y, Fang X, Liu B, Guan X . Cancer cell reprogramming: a promising therapy converting malignancy to benignity. Cancer Commun (Lond). 2019; 39(1):48. PMC: 6716904. DOI: 10.1186/s40880-019-0393-5. View